MARKET

SGMO

SGMO

Sangamo Therapeutics Inc
NASDAQ
0.5764
-0.0236
-3.93%
Opening 13:22 10/03 EDT
OPEN
0.5994
PREV CLOSE
0.6000
HIGH
0.6018
LOW
0.5612
VOLUME
792.08K
TURNOVER
0
52 WEEK HIGH
5.07
52 WEEK LOW
0.5600
MARKET CAP
102.09M
P/E (TTM)
-0.4870
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SGMO last week (0925-0929)?
Weekly Report · 2d ago
Sangamo Therapeutics 10% owner Biogen discloses sale of 6M shares
Seeking Alpha · 4d ago
Weekly Report: what happened at SGMO last week (0918-0922)?
Weekly Report · 09/25 09:26
Weekly Report: what happened at SGMO last week (0911-0915)?
Weekly Report · 09/18 09:25
Is Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Worth US$0.9 Based On Its Intrinsic Value?
Simply Wall St · 09/11 10:43
Weekly Report: what happened at SGMO last week (0904-0908)?
Weekly Report · 09/11 09:25
Sangamo Therapeutics: Recent Updates Bolster My Long-Term Conviction
Seeking Alpha · 09/08 09:36
Weekly Report: what happened at SGMO last week (0828-0901)?
Weekly Report · 09/04 12:17
More
About SGMO
Sangamo Therapeutics, Inc. is a clinical-stage genomic medicine company. The Company focuses on leveraging its optimized zinc finger (ZF) technology, which is a differentiated tool used to develop genomic medicines, including allogeneic cell therapies and in vivo genome engineering therapies. Its product candidates include Isaralgagene civaparvovec, also known as ST-920, its wholly owned gene therapy product candidate for the treatment of Fabry disease; TX200, its wholly owned Chimeric Antigen Receptor (CAR), engineered regulatory T cell (CAR-Treg) cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; Giroctocogene fitelparvovec, also known as SB-525, is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A., and BIVV003, its zinc finger nuclease, or ZF nuclease, gene-edited cell therapy product candidate for the treatment of sickle cell disease (SCD).

Webull offers kinds of Sangamo Therapeutics Inc stock information, including NASDAQ:SGMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGMO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SGMO stock methods without spending real money on the virtual paper trading platform.